Prior employment status and obesity do not predict post-stroke fatigue

IF 0.6 Q4 CLINICAL NEUROLOGY

Future Neurology Pub Date : 2022-08-17 DOI:10.2217/fnl-2021-0016

Zachary Cooper, N. Gilles, S. Levine, J. Weedon

引用次数: 0

Abstract

Aim: To investigate whether prior employment status or obesity pose as risk factors for post stroke fatigue in patients following an ischemic stroke. Materials & methods: A total of 121 patients with a confirmed diagnosis of ischemic stroke in the past 3 years were enrolled into the study. Post-stroke fatigue (PSF) was assessed using the fatigue assessment scale (no PSF ≤21, PSF 22–50). Patients were then identified based on their employment status (previously worked) or obesity (BMI) and compared with the presence of PSF. Results: A Fisher’s exact test was applied to determine the association between PSF and obesity (p = 1.000). A Fisher’s exact test was applied to show the association between PSF and employment status (p = 0.384). In logistic regression, employment status did not independently predict dichotomized fatigue assessment scale (adjusted odds ratio 1.34, 95% CI: 0.51–3.50, p = 0.557). Conclusion: Previous employment status and obesity did not independently predict PSF in an urban, minority community.

查看原文本刊更多论文

既往就业状况和肥胖不能预测卒中后疲劳

目的：研究既往工作状况或肥胖是否是缺血性卒中患者卒中后疲劳的危险因素。材料与方法：在过去3年中，共有121名确诊为缺血性中风的患者参与了这项研究。使用疲劳评估量表（无PSF≤21，PSF 22-50）评估卒中后疲劳（PSF）。然后根据患者的就业状况（以前工作过）或肥胖（BMI）确定患者，并与PSF的存在进行比较。结果：应用Fisher精确检验来确定PSF与肥胖之间的相关性（p=1.000）。应用Fisher精确测试来显示PSF与就业状况之间的关联（p=0.384）。在逻辑回归中，就业状况不能独立预测二分法疲劳评估量表（校正比值比1.34，95%CI:0.51-3.50，p=0.557）。结论：以前的就业状况和肥胖不能独立预测城市少数民族社区的PSF。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future Neurology CLINICAL NEUROLOGY-

CiteScore

2.10

自引率

0.00%

发文量

期刊介绍： The neurological landscape is changing rapidly. From the technological perspective, advanced molecular approaches and imaging modalities have greatly increased our understanding of neurological disease, with enhanced prospects for effective treatments in common but very serious disorders such as stroke, epilepsy, multiple sclerosis and Parkinson’s disease. Nevertheless, at the same time, the healthcare community is increasingly challenged by the rise in neurodegenerative diseases consequent upon demographic changes in developed countries.